← Leaderboards
Andrew S Goldstein
University Of California Los Angeles
$2,037,314
Attributed
$2,037,314
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $526K · FY2019–23$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,037,314 · 1
By mechanism
R01$2,037,314 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Li Xin$12,732,563
- Tanya I Stoyanova$7,579,166
- Heather Christofk$9,647,151
- Hong Wu$8,515,329
- Oliver None Hankinson$11,212,083
Others in their field
Other Emerging Leaders on “Resistance”
- John Damon Chodera · Sloan-Kettering Inst Can Research$56,843,703
- Urs Ochsner · Crestone, Inc.$40,390,611
- Ryan Cirz · Revagenix, Inc.$40,209,479
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Michael Dignam · National Institute Of Allergy And Infectious Diseases$30,845,607
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
Research focus
ResistanceExperimental StudyOrganoidsRegulationTargeted TreatmentUnited StatesMetabolicNovel Therapeutic InterventionExhibitsProstate Cancer ModelSmall Molecule InhibitorCastration Resistant Prostate CancerTherapeutic TargetTumorInnovationMalignant Neoplasm Of ProstateMetabolismNovel StrategiesCessation Of LifeCancer EtiologyAndrogen ReceptorProstateCellsGenetically Engineered Mouse
Grant awards (6)
The origins of metabolic reprogramming in prostate cancer$322,575
R01 · FY2023 · CA · contact PI
The origins of metabolic reprogramming in prostate cancer$276,187
R01 · FY2022 · CA · contact PI
The origins of metabolic reprogramming in prostate cancer$449,272
R01 · FY2021 · CA · contact PI
The Origins of Metabolic Reprogramming in Prostate Cancer$76,736
R01 · FY2021 · CA · contact PI
The origins of metabolic reprogramming in prostate cancer$449,272
R01 · FY2020 · CA · contact PI
The origins of metabolic reprogramming in prostate cancer$463,272
R01 · FY2019 · CA · contact PI